Accessibility Menu
Arrow-Thin-Down
S&P 500
6,869.50
+0.8%
+52.87
Arrow-Thin-Down
DJI
48,739.41
+0.5%
+238.14
Arrow-Thin-Down
NASDAQ
22,807.48
+1.3%
+290.79
Arrow-Thin-Down
Bitcoin
$72,560.00
+6.2%
+$4,250.88
Arrow-Thin-Down
VG
$11.15
-2.7%
-$0.31
Arrow-Thin-Down
MDB
$246.85
-2.3%
-$5.88
Arrow-Thin-Down
TGT
$120.08
-0.6%
-$0.72
Arrow-Thin-Down
SE
$88.26
+0.5%
+$0.44
Arrow-Thin-Down
PINS
$19.38
+1.4%
+$0.28
Arrow-Thin-Down
PLUG
$2.47
+10.8%
+$0.24
Arrow-Thin-Down
AMZN
$216.82
+3.9%
+$8.09
Arrow-Thin-Down
GOOG
$303.35
-0.1%
-$0.21
Arrow-Thin-Down
META
$667.98
+2.0%
+$12.90
Arrow-Thin-Down
MSFT
$405.30
+0.3%
+$1.37
Arrow-Thin-Down
NVDA
$183.08
+1.7%
+$3.03
Arrow-Thin-Down
TSLA
$405.94
+3.4%
+$13.51
Most Active StocksDaily Stock GainersDaily Stock Losers
Veeva Systems Stock Quote

Veeva Systems (NYSE: VEEV)

$188.31
(1.3%)
+2.40
Price as of March 4, 2026, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$188.31
Daily Change
(1.3%) +$2.40
Day's Range
$184.04 - $188.79
Previous Close
$188.31
Open
$185.01
Beta
1.06
Volume
244,064
Average Volume
2,010,131
Sector
Health Care
Market Cap
$31B
Market Cap / Employee
$185.91M
52wk Range
$168.14 - $310.50
Revenue
N/A
Gross Margin
0.75%
Dividend Yield
N/A
EPS
$5.15
CAPs Rating
N/A
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Veeva Systems Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
VEEV-15.09%-27.42%-6.21%+400%
S&P+16.53%+80.89%+12.59%+296%

Veeva Systems Company Info

Veeva Systems Inc is a provider of industry-specific cloud-based software solutions for the life sciences industry.

News & Analysis

The Fool has written over 300 articles on Veeva Systems.
Featured Article

1 Reason I'd Buy Veeva Systems Stock and Never Sell

It's worth sticking with the stock through the hard times.

Prosper Junior Bakiny  |  Feb 23, 2026
Featured Article

2 Top Stocks That Can Supercharge Your Portfolio in 2026 and Beyond

These winning stocks might be just getting started.

Prosper Junior Bakiny  |  Nov 13, 2025

Financial Health

General

Q4 2025YOY Change
Revenue$811.24M16.0%
Gross Profit$609.16M16.1%
Gross Margin75.09%0.0%
Market Cap$47.73B41.1%
Market Cap / Employee$6.55M0.0%
Employees7.3K0.0%
Net Income$236.20M27.1%
EBITDA$253.65M32.6%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$1.66B58.9%
Accounts Receivable$371.78M23.4%
Inventory00.0%

Liabilities

Q4 2025YOY Change
Long Term Debt$79.27M26.7%
Short Term Debt$10.53M15.0%

Ratios

Q4 2025YOY Change
Return On Assets11.83%0.4%
Return On Invested Capital13.42%-1.1%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$182.90M14.4%
Operating Free Cash Flow$192.79M17.5%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Earnings53.8749.5258.3156.589.67%
Price to Book6.886.517.467.1910.28%
Price to Sales14.0713.6016.0615.9723.14%
Price to Tangible Book Value7.557.108.087.747.51%
Price to Free Cash Flow TTM36.1332.7635.8836.4111.47%
Enterprise Value to EBITDA166.56133.11172.45168.139.16%
Free Cash Flow Yield2.8%3.1%2.8%2.7%-10.29%
Return on Equity13.6%14.1%13.7%13.7%1.79%
Total Debt$75.78M$77.23M$85.45M$89.80M25.24%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services